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Abstract
Macrodactyly is a rare family of congenital disorders characterized by the diffuse enlargement of 1 or more digits. Multiple
tissue types within the affected digits are involved, but skeletal patterning and gross morphological features are preserved.
Not all tissues are equally involved and there is marked heterogeneity with respect to clinical phenotype. The molecular
mechanisms responsible for these growth disturbances offer unique insight into normal limb growth and development, in
general. To date, no genes or loci have been implicated in the development of macrodactyly. In this study, we performed
the first transcriptional profiling of macrodactyly tissue. We found that pleiotrophin (PTN) was significantly overexpressed
across all our macrodactyly samples. The mitogenic functions of PTN correlate closely with the clinical characteristics of
macrodactyly. PTN thus represents a promising target for further investigation into the etiology of overgrowth phenotypes.
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Introduction
Macrodactyly is characterized by the diffuse enlargement of 1 or
more digits [1–3] (Fig. 1). It is a rare, congenital disease with no
familial inheritance pattern, and usually presents as an isolated,
non-syndromic condition. While all tissue elements are involved,
including fat, skin, nerve, and bone, histopathologic analysis of
macrodactyly tissue is usually remarkable for excess mature
adipose tissue [3].
We currently possess no modern molecular insight into
macrodactyly. No genes or loci have been implicated in the
development of this disease. Neither transcriptional nor protein-
level characterization of affected tissues is available. There are no
cellular or animal models of macrodactyly.
In this study, we performed the first transcriptional profiling of
macrodactyly tissue. We found that a developmental cytokine,
pleiotrophin (PTN), was significantly overexpressed across all our
macrodactyly samples. As a mitogen that has been implicated in
nerve, bone, vascular, and tumor growth, the functions of PTN
correlate closely with the clinical characteristics of macrodactyly.
PTN thus represents a promising target for further investigation.
Materials and Methods
This Project was reviewed and approved by the Children’s
Hospital Boston Institutional Review Board, Assurance #07-11-
0428 and by the Brigham & Women’s Hospital Institutional
Review Board, Assurance # FWA00000484. Pediatric patients
who underwent elective surgical debulkings of isolated, nonsyn-
dromic macrodactyly were eligible for this study. Additionally,
normal abdominal subcutaneous adipose tissue (SAT) samples
were obtained from patients undergoing elective surgeries at either
Massachusetts General Hospital or Children’s Hospital Boston.
During the review of this Project, the IRB specifically considered
(i) the risks and anticipated benefits, if any, to subjects; (ii) the
selection of subjects; (iii) the procedures for securing and
documenting informed consent; (iv) the safety of subjects; and (v)
the privacy of subjects and confidentiality of the data. Written
informed consent was obtained from guardians on the behalf of all
minors/children participants.
Approximately 5 mg of adipose tissue were harvested from each
patient and sectioned into smaller pieces. Samples were either
snap frozen in liquid nitrogen and stored at 280C or fixed in
either fresh 4% paraformaldehyde or 10% neutral buffered
formalin (Sigma Aldrich) for 4 hours, transferred to phosphate
buffered saline and stored in a 4 C refrigerator.
For each patient, RNA was extracted in biological triplicate via
submersion in 1 ml of Trizol, mechanical lysis using an RNase free
pestle (Kimble Chase Kontes), addition of 200 ml chloroform, and
centrifugation (10,000 g, 15 minutes, 4 C). The supernatant was
extracted and purified with RNeasy Mini Columns (Qiagen).
1.2 mg RNA was synthesized into complementary DNA (cDNA)
with the Superscript III First Strand Synthesis Kit (Invitrogen).
All RNA samples were analyzed for quality using an Agilent
2100 Bioanalyzer. Hybridization to Affymetrix Human Genome
U133 Plus 2.0 Arrays and subsequent array processing was done
by Asuragen. All data is MIAME compliant and the raw data has
been deposited in the Gene Expression Omnibus database
(accession number GSE35820). Adult SAT datasets were found
using the Expression Omnibus (GEO) [4] and ArrayExpress [5]
databases by searching for the terms ‘‘adipose’’ and ‘‘fat’’, and
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e40423restricting the platform to Affymetrix Human Genome U133 Plus
2.0 Arrays.
Raw expression values were analyzed with the Partek Genomics
Suite (Partek). Data were normalized using Robust Multiarray
Averaging (RMA) with median scaling, quintile normalization,
and background correction. The resulting datasets were prepro-
cessed to remove probesets whose minimum fold change
(maximum gene expression value divided by the minimum value)
was ,2, or whose difference between maximum and minimum
values was less than 100. Prinicipal component analysis was
performed, and linear models were used to identify statistically
significant, differentially expressed probe sets. Hierarchical clus-
tering was performed across all samples using the differentially
expressed probesets.
Figure 1. Clinical photos from patients undergoing surgical treatment of macrodactyly. (A) 15 month-old boy with macrodactyly
involving the thumb, index and middle fingers. As is often seen, there is associated syndactyly between the index and middle fingers and deviation of
all affected digits. (B) The same patient during separation and first stage debulking of the digits. The yellow loops are around the digital nerves, which
are enlarged. A large volume of overgrown fat and soft-tissue is being removed. (C) 8 year-old girl with macrodactyly isolated to the middle finger.
The excess fat and soft-tissue has been removed revealing enlarged digital nerves tagged with yellow loops.
doi:10.1371/journal.pone.0040423.g001
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mshri.on.ca/funcassociate/), which uses a Fisher’s exact test to
assess enrichment and a resampling approach to correct for
multiple hypotheses. For each of the sample populations, a false
discovery rate (FDR) of 0.01 was set as the threshold. The
differentially expressed probesets were uploaded into FuncAssoci-
ate 2.0 as ordered lists. Analysis was performed using the
hgnc_symbol namespace, with 1000 permutations for p-value
estimation and a p-value cutoff of 0.05.
For qPCR, expression levels of PTN were normalized to the
housekeeping gene hypoxanthine guanine phosphoribosyl trans-
ferase (HPRT) and measured via Quantifast SYBR Green PCR
Kit (Qiagen). To minimize the potential impact of any genomic
DNA contamination, primers were designed and verified to span
multiple exons. Three technical replicates were performed for
each sample. Error bars were computed by adding and subtracting
1 unit standard deviation of the delta Ct values from calibrated
delta Ct values. P-values were calculated in Microsoft Excel 2007
using 2-tailed heteroscedastic Student’s t-tests.
For immunohistochemical staining, tissues samples fixed in
freshly prepared 4% paraformaldehyde were dehydrated using an
ethanol gradient, sectioned (5-micron thickness), and mounted on
glass slides (Fisher). The sections were rehydrated and antigen
retrieval was performed using citric acid buffer (pH 6.0). The
sections were blocked using 5% donkey serum (Jackson Labs) with
0.01% Triton, and incubated with goat polyclonal anti-pleiotro-
phin antibody (1:100 dilution, Abcam ab10849). Bound anti-PTN
antibody was visualized using Alexa FluorH 546 donkey anti-goat
IgG (H+L) secondary antibody 1:700 (Invitrogen A-11056).
Images were captured using a Nikon Eclipse Ti-s.
DNA was isolated from our samples using a DNeasy Blood &
Tissue Kit (Qiagen). The isolates were analyzed for quality using
an Agilent 2100 Bioanalyzer. Sequencing of the promoter and
coding regions of PTEN was performed by Polymorphic DNA
Technologies.
Results
Between June 2009 and April 2011, 4 pediatric patients
(Patients 1 through 4) who underwent elective surgical debulkings
of isolated, nonsyndromic macrodactyly participated in the study.
Normal abdominal SAT from 2 adult patients (Patients 5 & 6) who
underwent elective surgeries at Massachusetts General Hospital
between June 2009 and March 2010 was obtained. Normal
abdominal SAT was also obtained from 1 pediatric patient
(Patient 7) who underwent an elective abdominal procedure at
Children’s Hospital Boston.
RNA was isolated from the 4 macrodactyly adipose tissue
samples and hybridized to Affymetrix U133A Plus 2.0 micro-
arrays. We sought to compare our samples against publicly
available data sets; since macrodactyly tissues are usually identified
as ‘‘mature adipose tissue’’ on histopathologic examination, we
chose subcutaneous adipose tissue (SAT) datasets as reference data
sets. No suitable data was available in the Gene Expression
Omnibus (GEO) [4] and ArrayExpress [5] databases for pediatric
samples, thus we performed our analysis against 4 adult SAT
datasets comprising 345 patients. Datasets GSE135063 [6],
GSE171704 [7], GSE157735 [8] were pooled and referred to as
the ‘‘GSM’’ pool. Dataset E-TABM-325 [8] was referred to as the
‘‘MolPAGE’’ pool.
To analyze these data, we performed principal component
analysis (Fig. 2A). The top 2 vectors accounted for 23.8% and
8.5% of inter-sample variation. This analysis demonstrated clear
separation between macrodactyly and SAT samples. We next
developed transcriptional profiles of macrodactyly and SAT. We
restricted our analysis to probe sets with false-discovery rates
(FDR) ,0.01, fold-changes $1.5, and p-values ,0.05. With these
stringent restrictions, we identified 3093 overexpressed and 4202
underexpressed genes. The large number of differentially ex-
pressed genes highlights the stark differences between macro-
dactyly and normal adipose tissue. The 10 features with the
highest fold-changes are shown in Table 1. When hierarchical
clustering was performed using these 7295 differentially expressed
genes, the macrodactyly samples clustered distinctly and distantly
from all SAT samples (Fig. 2B).
To better characterize the differentially expressed transcripts,
we performed unbiased gene enrichment analysis (GEA) using
FuncAssociate 2.0. [9] The 2 tissue types were each enriched for
different gene ontology categories (Table 2). In macrodactyly,
there was an enrichment of growth factor response (Table S1),
extracellular matrix (Table S2), and patterning (Table S3) genes.
In contrast, SAT was enriched for classic adipose tissue gene
categories such as regulation of fatty acid oxidation and response
to insulin (Table 2).
PTN was the most highly overexpressed gene in macrodactyly
(34.4-fold overexpression, p-value=0.00). The developmental
cytokine pleiotrophin was present in both the extracellular space
and pattern binding GO annotation categories (Tables S2 & S3).
To confirm these findings, we performed quantitative real time
polymerase chain reaction (qPCR) and found that in macro-
dactyly, PTN averaged 127.6-fold overexpression (p=0.049,
Fig. 3A).
In vivo, PTN is secreted into the extracellular space where it
binds to heparin. To demonstrate that transcriptional upregulation
of PTN resulted into protein overproduction, we analyzed sections
from adipose tissue from a patient with macrodactyly (Patient 4)
and pediatric SAT (Patient 6) tissue for PTN immunoreactivity.
We found no PTN staining in pediatric SAT (Fig. 4A). In contrast,
macrodactyly sections were marked by widespread punctate
expression of PTN (Fig. 4B). This assay did not allow the
localization of PTN expression to a specific cell type. We
attempted to quantify PTN overexpression by Western blot
[10,11] but the small volume of our samples made this technically
infeasible. Li et al. reported that deletion of phosphatase and
tensin homologue (PTEN) was associated with PTN upregulation
[12]. We thus isolated DNA from our macrodactyly samples and
sequenced the PTEN promoter and coding regions. No mutations
were identified (data not shown).
Discussion
Macrodactyly remains a difficult clinical problem, one with an
unknown etiology. Modern treatment strategies are strictly surgical
and involve either growth-limiting or digit reducing procedures,
or, in severe cases, finger amputation [2,3,13]. Prior to this study,
no molecular information was available regarding this disease.
Given the absence of molecular data, we elected to first generate
transcriptional profiles of macrodactyly tissue. Analysis of this data
identified 7295 differentially expressed genes in macrodactyly
compared to adult SAT. The candidate genes overexpressed in
macrodactyly include well-characterized mitogens such as bone-
morphogenetic proteins 5 & 7, transforming growth factor beta 3,
and Wnt signaling pathway members (WNT2, WNT5A) (Tables
S1 & S2). However, the mitogen with the highest fold-change
overexpression was pleiotrophin (Table 1).
To characterize our samples at the biological pathway level, we
performed gene enrichment analysis. This again underscored the
differences between SAT and macrodactyly: SAT was enriched for
Expression Analysis Macrodactyly
PLoS ONE | www.plosone.org 3 July 2012 | Volume 7 | Issue 7 | e40423Figure 2. Results of principal component analysis (PCA) and hierarchical clustering of gene expression date from macrodactyly
samples. (A) PCA of 4 macrodactyly samples (in triplicate) vs. 345 subcutaneous adipose tissue (SAT) samples. The top 2 vectors account 32.3% of
intersample variation. Macrodactyly samples cluster distinctly from SAT. (B) Hierarchical clustering of macrodactyly and SAT samples across
differentially expressed genes with fold-change .1.5, p-value ,0.05, and false discovery rate ,0.05. Macrodactyly samples cluster distinctly and
distantly from all SAT samples.
doi:10.1371/journal.pone.0040423.g002
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catabolic processes’’ and ‘‘response to insulin stimulus’’ (Table 2).
In contrast, macrodactyly tissues demonstrated enrichment of the
gene ontology (GO) categories such as ‘‘extracellular space’’ and
‘‘pattern binding’’ (Table 2).
Interestingly, PTN was present in both of these GO categories
(Tables S2 & S3). This fact, combined with its rank as the gene
with the greatest fold-change overexpression on microarray
analysis, led us to perform confirmatory experiments on this
candidate gene. At the transcriptional level, qPCR confirmed
PTN overexpression in macrodactyly compared to adult abdom-
inal SAT, a depot known for its remarkable proliferative capacity
(Fig 3A). While PTN was overexpressed in all macrodactyly
samples, the degree of overexpression varied greatly between
patients, with overexpression levels being lowest in patient 1.
There were insufficient samples to correlate PTN overexpression
levels with clinical phenotype, but it is possible that lower
overexpression corresponds with milder disease. At the protein
level, immunohistochemical staining revealed punctate aggregates
of PTN in macrodactyly (Fig. 4B). Control pediatric finger adipose
tissue from a patient with polydactyly demonstrated no PTN
staining (Fig. 4A).
Pleiotrophin is a promising candidate gene for the pathogenesis
of macrodactyly because it promotes growth of nearly all the
tissues affected by macrodactyly, including nerve, skin, bone, and
cartilage. An 18-kDa protein, PTN was the first developmentally
regulated cytokine to be discovered [14]. Its amino acid sequence
is the most highly conserved between human, bovine, rat, mouse,
and chicken cytokines [15]. It possesses 50% sequence homology
with midkine [11,15].
Pleiotrophin has been variously referred to as heparin-binding
growth-associated molecule (HB-GAM), heparin-binding neurite
outgrowth-promoting factor 1 (HBNF1), and osteoblast-stimulat-
ing factor 1 (OSF-1). This variety of names reflects its diverse
mitogenic functions. In neural cells, PTN is necessary for proper
neurite outgrowth and maturation in the central nervous system
[14,16,17]. In the peripheral nervous system it promotes nerve
regeneration following injury [11]. PTN is highly expressed in
vivo in bone and cartilage, and is upregulated in response to
mechanical loading [18,19,20]. As an angiogenic factor, PTN
supports endothelial cell proliferation [21]. PTN has also been
implicated in a number of tumors including glioblastoma [22,23]
and breast cancer [24,25], and its overexpression has been
reported to cause malignant transformation in several cell lines
[15,26]. While one study suggested that PTN inhibits adipogen-
esis, the findings were indirect and only used an in vitro model
[27].
The overlap between the physiologic functions of PTN and
the clinical phenotype of macrodactyly is striking. In neural
cells, PTN directs nerve growth and regeneration; clinicians
have long noted that macrodactyly nerves are unusually large
[3,28,29]. PTN has been demonstrated to be osteogenic and
chondrogenic; one of the hallmarks of macrodactyly is persistent
bone and joint overgrowth. As a protooncogene, PTN drives
Table 1. Top 10 greatest fold-change probesets in macrodactyly and subcutaneous adipose tissue.
Overexpressed in Macrodactyly
Probeset ID Gene Description p-value Fold-Change (vs. SAT)
209465_x_at PTN pleiotrophin 0 34.44
223475_at CRISPLD1 cysteine-rich secretory protein LCCL domain containing 1 1.85E-42 21.42
211737_x_at PTN pleiotrophin 0 19.86
220504_at KERA keratocan 0 18.51
203913_s_at HPGD hydroxyprostaglandin dehydrogenase 15-(NAD) 1.40E-45 15.71
216834_at RGS1 regulator of G-protein signaling 1 2.72E-25 14.19
205430_at BMP5 bone morphogenetic protein 5 0 13.97
209466_x_at PTN pleiotrophin 0 12.97
209189_at FOS FBJ murine osteosarcoma viral oncogene homolog 3.03E-15 12.82
203700_s_at DIO2 deiodinase, iodothyronine, type II 0 12.35
Overexpressed in SAT
Probeset ID Gene Description p-value Fold-Change (vs. Macrodactyly)
214456_x_at SAA1///SAA2 serum amyloid A1///serum amyloid A2 4.20E-45 91.68
208607_s_at SAA1///SAA2 serum amyloid A1///serum amyloid A2 4.84E-26 72.59
204424_s_at LMO3 LIM domain only 3 (rhombotin-like 2) 0 17.56
214146_s_at PPBP pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) 1.72E-21 16.27
228434_at BTNL9 butyrophilin-like 9 0 14.31
211699_x_at HBA1///HBA2 hemoglobin, alpha 1///hemoglobin, alpha 2 0 14.28
209458_x_at HBA1///HBA2 hemoglobin, alpha 1///hemoglobin, alpha 2 0 13.49
204018_x_at HBA1///HBA2 hemoglobin, alpha 1///hemoglobin, alpha 2 0 12.66
204105_s_at NRCAM neuronal cell adhesion molecule 2.39E-27 12.49
229778_at C12orf39 chromosome 12 open reading frame 39 1.78E-09 12.35
doi:10.1371/journal.pone.0040423.t001
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soft tissue elements are overgrown in macrodactyly. In many
patients, macrodactylous overgrowth is proportionally patterned
among all tissues of the affected region. The means by which
this specific, patterned overgrowth occurs is not known.
Table 2. Enriched gene ontology categories in macrodactyly and subcutaneous adipose tissue.
# of genes P-adjusted GO ID GO Category
Upregulated in Macrodactyly
6 0.001 GO:0071363 cellular response to growth factor stimulus
6 0.039 GO:0070848 response to growth factor stimulus
10 0.048 GO:0030199 collagen fibril organization
18 0.011 GO:0001501 skeletal system development
19 0 GO:0005578 proteinaceous extracellular matrix
22 0 GO:0031012 extracellular matrix
30 0 GO:0005539 glycosaminoglycan binding
34 0 GO:0001871 pattern binding
34 0 GO:0030247 polysaccharide binding
41 0 GO:0005615 extracellular space
41 0 GO:0009611 response to wounding
42 0.01 GO:0008284 positive regulation of cell proliferation
47 0 GO:0048731 system development
48 0.008 GO:2000026 regulation of multicellular organismal development
49 0.023 GO:0005102 receptor binding
51 0 GO:0044421 extracellular region part
52 0.023 GO:0009653 anatomical structure morphogenesis
59 0 GO:0007166 cell surface receptor linked signaling pathway
77 0 GO:0005576 extracellular region
Upregulated in Subcutaneous Adipose Tissue
3 0.002 GO:0015671 oxygen transport
3 0.008 GO:0005833 hemoglobin complex
3 0.012 GO:0015669 gas transport
3 0.012 GO:0005344 oxygen transporter activity
5 0 GO:0004556 alpha-amylase activity
5 0 GO:0016160 amylase activity
6 0.044 GO:0003823 antigen binding
12 0.013 GO:0003995 acyl-CoA dehydrogenase activity
17 0 GO:0046320 regulation of fatty acid oxidation
24 0.023 GO:0032869 cellular response to insulin stimulus
36 0.004 GO:0032868 response to insulin stimulus
43 0 GO:0001525 angiogenesis
55 0.013 GO:0051056 regulation of small GTPase mediated signal transduction
57 0.04 GO:0035467 negative regulation of signaling pathway
60 0.049 GO:0006732 coenzyme metabolic process
71 0.01 GO:0051270 regulation of cellular component movement
87 0.004 GO:0009894 regulation of catabolic process
96 0 GO:0005083 small GTPase regulator activity
123 0.004 GO:0030695 GTPase regulator activity
124 0.007 GO:0060589 nucleoside-triphosphatase regulator activity
197 0.015 GO:0046907 intracellular transport
204 0.012 GO:0019899 enzyme binding
222 0.04 GO:0035466 regulation of signaling pathway
234 0 GO:0044248 cellular catabolic process
doi:10.1371/journal.pone.0040423.t002
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PLoS ONE | www.plosone.org 6 July 2012 | Volume 7 | Issue 7 | e40423Figure 3. Confirmation of pleiotrophin (PTN) expression in macrodactyly and the known PTN signaling cascade. (A) Relative
expression of PTN in macrodactyly vs. adult subcutaneous adipose tissue as determined by quantitative real time polymerase chain reaction. In
macrodactyly, PTN averaged 127.6-fold overexpression (p=0.049). (B) The PTN signaling cascade and crosstalk with Wnt signalling (from Deuel et
al.)
14.
doi:10.1371/journal.pone.0040423.g003
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PLoS ONE | www.plosone.org 7 July 2012 | Volume 7 | Issue 7 | e40423Figure 4. Pleiotrophin (PTN) immunostaining. DAPI = nuclear stain, PTN = antibody staining for pleiotrophin, Merge = composite image
merging Brightfield, DAPI, and PTN channels. A) No PTN is seen in pediatric subcutaneous adipose tissue from Patient 7. B) Large PTN aggregates are
seen in macrodactyly patient 4.
doi:10.1371/journal.pone.0040423.g004
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macrodactyly was recently suggested by the discovery of an
activating AKT1 mutation in Proteus syndrome [30]. This
mutation leads to constitutive phosphorylation of residues
Ser473 and Thr308 in AKT1. PTN, on the other hand, has been
shown to rapidly phosphorylate Ser473 of AKT1 in a dose-
dependent manner [31]. This link is particularly intriguing
because partial gigantism of the hands and/or feet is a hallmark
of Proteus syndrome [32]. Unfortunately, phosphorylation of this
specific residue is also consistent with rapid proliferation and thus,
the use of this biomarker would not be conclusive as to mechanism
of overgrowth. For this reason, testing for phosphorylation of
residue Ser473 in AKT1 was not performed.
Little is currently known about the regulation of PTN. While it
has been reported that PTEN deletion is associated with PTN
upregulation, this is indirect and the direct regulation of PTN
stemming from PTEN deletion is unknown [12]. Our microarray
data did not demonstrate reduction of PTEN levels in macro-
dactyly (data not shown) and sequencing of the PTEN locus in
macrodactyly samples yielded no mutations.
This study was limited by the unavailability of normal pediatric
finger adipose tissue. Only under rare circumstances would it be
ethical to remove a significant amount of tissue from a child’s hand
for research purposes. Some pediatric hand conditions, such as
polydactyly, are managed by finger amputation and therefore are
potential sources of pediatric finger adipose tissue. However, these
conditions can be caused by germline genetic mutations and
therefore are not strictly normal [33]. Because of these limitations,
we believe future research will require in vitro and animal models of
macrodactyly. The identification of PTN as the first macrodactyly
candidate gene points the way towards the development of critical
research tools.
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